Ingevity (NYSE:NGVT) Posts Quarterly Earnings Results

Ingevity (NYSE:NGVT) issued its earnings results on Tuesday. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.29 by $0.66, Zacks reports. The company had revenue of $298.80 million for the quarter, compared to analyst estimates of $297.40 million. Ingevity had a negative net margin of 30.60% and a positive return on equity of 36.76%. Ingevity updated its FY 2025 guidance to EPS.

Ingevity Price Performance

Shares of NYSE:NGVT traded down $0.50 during midday trading on Thursday, hitting $47.76. 9,412 shares of the stock were exchanged, compared to its average volume of 206,663. The company has a 50 day moving average price of $43.33 and a 200-day moving average price of $40.98. Ingevity has a twelve month low of $30.90 and a twelve month high of $56.29. The stock has a market cap of $1.74 billion, a P/E ratio of -4.06 and a beta of 1.64. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 6.52.

Wall Street Analysts Forecast Growth

Separately, BMO Capital Markets lifted their price target on Ingevity from $61.00 to $62.00 and gave the stock a “market perform” rating in a research note on Thursday. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $54.67.

About Ingevity

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.